Inflammatory Myositis in the Elderly

Primary Types of Inflammatory Myopathies

The American College of Physicians recommends considering dermatomyositis (DM) in elderly patients with symmetric proximal muscle weakness, elevated muscle enzymes, and distinctive skin manifestations (heliotrope rash, Gottron papules, periungual telangiectasias) 1
Polymyositis (PM) is characterized by symmetric proximal muscle weakness with CD8+ cytotoxic T cells invading non-necrotic muscle fibers, according to the Mayo Clinic Proceedings 4
Immune-Mediated Necrotizing Myopathy (IMNM) presents with severe proximal muscle weakness, markedly elevated creatine kinase (CK) levels, and minimal inflammatory infiltrate on muscle biopsy, as reported by the Mayo Clinic Proceedings 3, 5
Sporadic Inclusion Body Myositis (sIBM) shows degenerative features with muscle fiber vacuolization and abnormal accumulation of amyloid-β and phosphorylated tau proteins, according to the Mayo Clinic Proceedings 4, 6

Statins are a major trigger for immune-mediated necrotizing myopathy, associated with antibodies against 3-hydroxy-3-methylglutaryl-coenzyme A (HMGCR) protein, as reported by the Mayo Clinic Proceedings 5
Immune Checkpoint Inhibitors (ICPIs) can cause severe and potentially fatal myositis, more common with anti-PD-1/PD-L1 than with anti-CTLA-4 agents, according to the Journal of Clinical Oncology 7, 8

Laboratory evaluation should include checking muscle enzymes (CK, aldolase), inflammatory markers (ESR, CRP), and myositis-specific autoantibodies, as recommended by the Journal of Clinical Oncology 7, 8
Imaging with MRI can identify muscle inflammation and guide biopsy site selection, according to the Mayo Clinic Proceedings 4
Electromyography (EMG) may show polyphasic motor unit action potentials of short duration and low amplitude with increased insertional and spontaneous activity, as reported by the Mayo Clinic Proceedings 1
Muscle biopsy is essential for definitive diagnosis and classification of myositis subtype, according to the Mayo Clinic Proceedings 1, 4

Elderly patients with inflammatory myositis have a higher risk of malignancy and statin exposure, as reported by the Mayo Clinic Proceedings 3, 5
Differential diagnosis should distinguish inflammatory myositis from polymyalgia rheumatica, which presents with pain but not true weakness and normal CK levels, according to the Journal of Clinical Oncology 7
Comorbidities can complicate diagnosis and treatment in elderly patients, as reported by the Mayo Clinic Proceedings 4
Treatment challenges in elderly patients may include increased risk of immunosuppressive therapy complications, requiring careful monitoring, according to the Mayo Clinic Proceedings 4, 5
Prognosis factors associated with poorer outcomes include advanced age, presence of dysphagia, cardiac involvement, and associated malignancy, as reported by the Mayo Clinic Proceedings 1, 5